Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc. is a pioneering company in the field of synthetic biology, focusing on the design and growth of bespoke organisms. Its primary function is to engineer biological processes to produce custom organisms that can be utilized across numerous industries, including agriculture, pharmaceuticals, food, and biofuels. Notably, the company's platform allows for the programming of cells, enabling innovations that can drive efficiencies and advancements in those sectors. Ginkgo Bioworks stands out due to its unique business model, which leverages the power of genetic coding to develop sustainable solutions and innovative products for its clients. The company operates a "cell programming" platform, akin to a computer operating system, which allows it to execute complex biological designs at scale. This role places Ginkgo Bioworks at the forefront of the biotechnology sector, as it seeks to revolutionize how biological resources are utilized and managed. With its headquarters in Boston, Massachusetts, Ginkgo is positioned as a key player in the global push towards a more sustainable bioeconomy.